Resistance training attenuates circulating FGF-21 and myostatin and improves insulin resistance in elderly men with and without type 2 diabetes mellitus: A randomised controlled clinical trial
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Fibroblast growth factor 21 (FGF-21) and myostatin have been proposed to be potential therapeutic target for insulin resistance in age-related metabolic disorders including type 2 diabetes (T2D). Moreover, despite the potential metabolic effect of resistance training on insulin resistance, aging, and T2D; the effect of this type of exercise training on FGF-21 and myostatin in elderly men with and without T2D are unknown. Forty-four elderly men were assigned to either the RT training (RT; without T2D: 12, with TD2 = 10) or the control group (C; without T2D: 12, with TD2 = 10). The RT group performed 12-wk resistance training intervention, 3 days/wk, 10 repetitions with 70% 1RM. At the baseline, the elderly men with T2D had a higher FGF-21 ( p = 0.002) and myostatin ( p = 0.02) concentrations and lower muscle strength ( p = 0.01) than the elderly men without T2D. RT resulted in significant decrease in FGF-21 and myostatin concentration and increase in muscle strength in both elderly men with and without T2D ( P = 0.001, for all) as well as decrease in HOMA-IR in only elderly men without T2D ( P = 0.001). There was no significant difference in the RT-induced FGF-21 reduction between elderly men with and without T2D ( p = 0.77, p = 0.28, respectively), but, RT caused a larger reduction in circulating myostatin in elderly men without T2D than with T2D ( P = 0.007). Taken together, our results demonstrated that 12 weeks of RT induced an overall significant reduction of FGF-21 and m…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term regular exercise persistently lowers baseline MSTN levels in both skeletal muscle and circulation, and performing acute exercise again after long-term training leads to further reduction in MSTN expression [21,22,59].”
From Exercise-Induced Myokines in Obesity-Related Metabolic Disorders and Cardiovascular Protection: A Narrative Review (2026) · cites this paper as [21]
In the citing paper
“Resistance training is the most effective exercise modality for downregulating MSTN expression.”
From Exercise-Induced Myokines in Obesity-Related Metabolic Disorders and Cardiovascular Protection: A Narrative Review (2026) · cites this paper as [21]
In the citing paper
“Studies indicate that both former weightlifters and sedentary men show decreased MSTN mRNA levels in leg muscles after acute resistance training [21].”
From Exercise-Induced Myokines in Obesity-Related Metabolic Disorders and Cardiovascular Protection: A Narrative Review (2026) · cites this paper as [21]
In the citing paper
“Metabolically, exercise-induced MSTN downregulation represents an important mechanism through which exercise enhances muscle mass, improves body composition, and increases insulin sensitivity [21,22,59].”
From Exercise-Induced Myokines in Obesity-Related Metabolic Disorders and Cardiovascular Protection: A Narrative Review (2026) · cites this paper as [21]
In the citing paper
“Metabolically, exercise-induced MSTN downregulation represents an important mechanism through which exercise enhances muscle mass, improves body composition, and increases insulin sensitivity [21,22,59].”
From Exercise-Induced Myokines in Obesity-Related Metabolic Disorders and Cardiovascular Protection: A Narrative Review (2026) · cites this paper as [21]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Understanding the Physiology of FGF21
Fisher, F. M., & Maratos-Flier, E. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105339 · Cited by 912 · cited 1×
“As a member of the endocrine FGFs subfamily, FGF-21 is abundantly expressed in the liver (Inagaki, 2015), but also by other tissue types including skeletal muscle under stress (Fisher & Maratos-Flier, 2016).”
BackgroundObesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Fisher, F. M., Chui, P. C., Antonellis, P. J., Bina, H. A., Kharitonenkov, A., Flier, J. S., & Maratos-Flier, E. (2010) · Diabetes · doi:10.2337/db10-0193 · Cited by 830 · cited 1×
“Previous studies reported decreases in the expression of FGF-21 receptors includes FGFR1c, FGFR2 and FGFR3, and the co-receptor β-Klotho in metabolic disorders such as obesity and diabetes (Chui et al., 2010; Kruse, Vienberg, Vind, Andersen, & Højlund, 2017).”
BackgroundNeural Adaptations to Resistive Exercise: Mechanisms and Recommendations for Training Practices
Gabriel, D. A., Kamen, G., & Frost, G. (2006) · Sports Medicine · doi:10.2165/00007256-200636020-00004 · Cited by 794
Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Lee, J. S., Kuller, L. H., Boudreau, R., de Rekeneire, N., Harris, T. B., Kritchevsky, S., Tylavsky, F. A., Nevitt, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0264 · Cited by 778 · cited 1×
“Our results demonstrate that T2D associated with reduction in muscle strength, and decreases in muscle strength commonly observed with diabetes are greatly related to impairments in loss of muscle mass (Park et al., 2006, 2007, 2009).”
ResultHigh-intensity resistance training improves glycemic control in older patients with type 2 diabetes
Dunstan, D. W., Daly, R. M., Owen, N., Jolley, D., de Courten, M., Shaw, J., & Zimmet, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1729 · Cited by 771
Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766 · cited 1×
“Our results demonstrate that T2D associated with reduction in muscle strength, and decreases in muscle strength commonly observed with diabetes are greatly related to impairments in loss of muscle mass (Park et al., 2006, 2007, 2009).”
ResultDecreased Muscle Strength and Quality in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., & Newman, A. B. (2006) · Diabetes · doi:10.2337/db05-1183 · Cited by 751 · cited 1×
“Our results demonstrate that T2D associated with reduction in muscle strength, and decreases in muscle strength commonly observed with diabetes are greatly related to impairments in loss of muscle mass (Park et al., 2006, 2007, 2009).”
ResultWillis, L. H., Slentz, C. A., Bateman, L. A., Shields, A. T., Piner, L. W., Bales, C. W., Houmard, J. A., & Kraus, W. E. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01370.2011 · Cited by 496
Effects of Exercise and Aging on Skeletal Muscle
Distefano, G., & Goodpaster, B. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029785 · Cited by 479
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J. C., Hadj Sassi, A., Seiliez, I., Picard, B., & Bonnieu, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1689-x · Cited by 397 · cited 6×
“…(Camporez et al., 2016). myostatin is mainly produced in skeletal muscle in an autocrine/paracrine manner via binding to Activin receptor type IIA and IIB (ActRIIA and ActRIIB), and increases the activity of the ubiquitin–proteasome system resulting in muscle atrophy (Rodriguez et al., 2014).”
BackgroundResultInfluentialIncreased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324
Vechin, F. C., Libardi, C. A., Conceição, M. S., Damas, F. R., Lixandrão, M. E., Berton, R. P. B., Tricoli, V. A. A., Roschel, H. A., Cavaglieri, C. R., Chacon-Mikahil, M. P. T., et al. (2015) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000000703 · Cited by 292
Acute Exercise Induces FGF21 Expression in Mice and in Healthy Humans
Kim, K. H., Kim, S. H., Min, Y.-K., Yang, H.-M., Lee, J.-B., & Lee, M.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063517 · Cited by 290
Myostatin decreases with aerobic exercise and associates with insulin resistance
HITTEL, D. S., AXELSON, M., SARNA, N., SHEARER, J., HUFFMAN, K. M., & KRAUS, W. E. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0b9a8 · Cited by 271 · cited 2×
“However, these studies have used other types of exercise training such as aerobic training with and without weight loss (Hittel et al., 2010; Ryan, Li, Blumenthal, & Ortmeyer, 2013), combined training (aerobic and resistance training) (So & Han, 2016), and resistance training (Hofmann et al., 2016)…”
ResultDONGES, C. E., DUFFIELD, R., & DRINKWATER, E. J. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b117ca · Cited by 258
Way, K. L., Hackett, D. A., Baker, M. K., & Johnson, N. A. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.4.253 · Cited by 244
Ashton, R. E., Tew, G. A., Aning, J. J., Gilbert, S. E., Lewis, L., & Saxton, J. M. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098970 · Cited by 238
Besse-Patin, A., Montastier, E., Vinel, C., Castan-Laurell, I., Louche, K., Dray, C., Daviaud, D., Mir, L., Marques, M.-A., Thalamas, C., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2013.158 · Cited by 227 · cited 3×
“However, other studies in obese men (Besse-Patin et al., 2014) did not report any changes in plasma and circulating levels of FGF-21 after eight and 12 weeks of endurance exercise training.”
BackgroundMashili, F. L., Austin, R. L., Deshmukh, A. S., Fritz, T., Caidahl, K., Bergdahl, K., Zierath, J. R., Chibalin, A. V., Moller, D. E., Kharitonenkov, A., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1177 · Cited by 221
Geng, L., Liao, B., Jin, L., Huang, Z., Triggle, C. R., Ding, H., Zhang, J., Huang, Y., Lin, Z., & Xu, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.014 · Cited by 198
Roth, S. M., Martel, G. F., Ferrell, R. E., Metter, E. J., Hurley, B. F., & Rogers, M. A. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800609 · Cited by 184
Camporez, J.-P. G., Petersen, M. C., Abudukadier, A., Moreira, G. V., Jurczak, M. J., Friedman, G., Haqq, C. M., Petersen, K. F., & Shulman, G. I. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525795113 · Cited by 184 · cited 6×
“Previous studies have shown that myostatin inhibits glucose uptake (Camporez et al., 2016), suggesting that it may contribute to systemic insulin resistance.”
BackgroundResultInfluentialTomeleri, C. M., Ribeiro, A. S., de Souza, M. F., Bortoloti, D. S., Schoenfeld, B. J., Venturini, D., Barbosa, D. S., Bonifácio, K. L., Sardinha, L. B., & Cyrino, E. S. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.09.005 · Cited by 157
Yang, S. J., Hong, H. C., Choi, H. Y., Yoo, H. J., Cho, G. J., Hwang, T. G., Baik, S. H., Choi, D. S., Kim, S. M., & Choi, K. M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04078.x · Cited by 147
Nicklas, B. J., Chmelo, E., Delbono, O., Carr, J. J., Lyles, M. F., & Marsh, A. P. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.105270 · Cited by 144 · cited 1×
“As previously reported (Nicklas et al., 2015), the machines used were leg press, leg extension, seated leg curl, seated calf, bench press, compound row, triceps press, and bicep curl.”
MethodResistance Training Alters Plasma Myostatin but not IGF-1 in Healthy Men
WALKER, K. S., KAMBADUR, R., SHARMA, M., & SMITH, H. K. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000126384.04778.29 · Cited by 141
FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1477-1 · Cited by 127
Fibroblast Growth Factor 21 Predicts the Metabolic Syndrome and Type 2 Diabetes in Caucasians
Bobbert, T., Schwarz, F., Fischer-Rosinsky, A., Pfeiffer, A. F. H., Möhlig, M., Mai, K., & Spranger, J. (2013) · Diabetes Care · doi:10.2337/dc12-0703 · Cited by 123
Hansen, J. S., Pedersen, B. K., Xu, G., Lehmann, R., Weigert, C., & Plomgaard, P. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1681 · Cited by 106
Hofmann, M., Schober-Halper, B., Oesen, S., Franzke, B., Tschan, H., Bachl, N., Strasser, E.-M., Quittan, M., Wagner, K.-H., & Wessner, B. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3344-8 · Cited by 102
Taniguchi, H., Tanisawa, K., Sun, X., Kubo, T., & Higuchi, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3308 · Cited by 100
Giannini, C., Feldstein, A. E., Santoro, N., Kim, G., Kursawe, R., Pierpont, B., & Caprio, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1250 · Cited by 95
Serum Myostatin is Upregulated in Obesity and Correlates with Insulin Resistance in Humans
Amor, M., Itariu, B. K., Moreno-Viedma, V., Keindl, M., Jürets, A., Prager, G., Langer, F., Grablowitz, V., Zeyda, M., & Stulnig, T. M. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0641-5546 · Cited by 93 · cited 2×
“myostatin was also shown to be negatively associated with insulin sensitivity (Amor et al., 2019), and previous studies have reported that treatment with an antiMyostatin antibody improved muscle insulin sensitivity as well as increased muscle mass and muscle strength in old mice (Camporez et al.”
BackgroundResultBanitalebi, E., Kazemi, A., Faramarzi, M., Nasiri, S., & Haghighi, M. M. (2019) · Life Sciences · doi:10.1016/j.lfs.2018.11.062 · Cited by 93
Hsieh, P.-L., Tseng, C.-H., Tseng, Y. J., & Yang, W.-S. (2018) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0000000000000107 · Cited by 87
Bagheri, R., Rashidlamir, A., Motevalli, M. S., Elliott, B., Mehrabani, J., & Wong, A. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04180-z · Cited by 85
Prevalence of diabetes in Brazil over time: a systematic review with meta-analysis
Telo, G. H., Cureau, F. V., de Souza, M. S., Andrade, T. S., Copês, F., & Schaan, B. D. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0181-1 · Cited by 81
Planella-Farrugia, C., Comas, F., Sabater-Masdeu, M., Moreno, M., Moreno-Navarrete, J. M., Rovira, O., Ricart, W., & Fernández-Real, J. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00871 · Cited by 73
Ryan, A. S., Li, G., Blumenthal, J. B., & Ortmeyer, H. K. (2013) · Obesity · doi:10.1002/oby.20216 · Cited by 72
Kruse, R., Vienberg, S. G., Vind, B. F., Andersen, B., & Højlund, K. (2017) · Diabetologia · doi:10.1007/s00125-017-4373-5 · Cited by 72
Konopka, A. R., Wolff, C. A., Suer, M. K., & Harber, M. P. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00030.2018 · Cited by 59
Cheung, N. W., Cinnadaio, N., Russo, M., & Marek, S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.009 · Cited by 57
Inagaki, T. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00147 · Cited by 55
Time Course of Resistance Training–Induced Muscle Hypertrophy in the Elderly
Lixandrão, M. E., Damas, F., Chacon-Mikahil, M. P. T., Cavaglieri, C. R., Ugrinowitsch, C., Bottaro, M., Vechin, F. C., Conceição, M. S., Berton, R., & Libardi, C. A. (2016) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000001019 · Cited by 54
Diel, P. R., Schiffer, T., Geisler, S., Hertrampf, T., Mosler, S., Schulz, S., Wintgens, K. F., & Adler, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.015 · Cited by 41
Myostatin regulates glucose uptake in BeWo cells
Antony, N., Bass, J. J., McMahon, C. D., & Mitchell, M. D. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00331.2007 · Cited by 39
Ribeiro, A. S., Aguiar, A. F., Schoenfeld, B. J., Nunes, J. P., Cavalcante, E. F., Cadore, E. L., & Cyrino, E. S. (2017) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000002326 · Cited by 39
Takenami, E., Iwamoto, S., Shiraishi, N., Kato, A., Watanabe, Y., Yamada, Y., Yamada, S., & Ishii, N. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12926 · Cited by 38
Ye, X., Qi, J.-Y., Yu, D., Wu, Y.-Z., Zhu, S.-L., Li, S.-J., Wu, Q., Ren, G.-P., & Li, D.-S. (2017) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2017.01.008 · Cited by 27
Kazemi, F. (2019) · Cytokine · doi:10.1016/j.cyto.2019.04.012 · Cited by 20
Han, T., & So, W.-Y. (2016) · South African Journal for Research in Sport Physical Education and Recreation · Cited by 2
Cited by
García-Hermoso, A., Ramírez-Vélez, R., Díez, J., González, A., & Izquierdo, M. (2023) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2022.11.003 · Cited by 80
Hekmatikar, A. H. A., Ferreira‐Júnior, J. B., Shahrbanian, S., & Suzuki, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042290 · Cited by 86
Al-Mhanna, S. B., Franklin, B. A., Jakicic, J. M., Stamatakis, E., Pescatello, L. S., Riebe, D. A., Thompson, W. R., Skinner, J. S., Colberg, S. R., Alkhamees, N. H., et al. (2025) · British Journal of Sports Medicine · doi:10.1136/bjsports-2024-108947 · Cited by 85
Wołosowicz, M., Prokopiuk, S., & Kaminski, T. W. (2022) · Medicina · doi:10.3390/medicina58040472 · Cited by 77
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041917 · Cited by 56
“Resistance training can reduce myostatin levels, leading to the improvement of insulin resistance [59].”
Background
Metadata
- Authors
- Shabkhiz, F., Khalafi, M., Rosenkranz, S., Karimi, P., & Moghadami, K.
- Affiliations
- University of Tehran (IR)
- University of Guilan (IR)
- Kansas State University (US)
- Tabriz University of Medical Sciences (IR)
- Department of pure and basic science, Hashtgerd Branch Islamic Azad University Karaj Iran
- Corresponding author
- Shabkhiz, Fatemeh
- Venue
- European Journal of Sport Science
- Publisher
- Wiley
- Published
- 2020-05-26
- Volume
- 21
- Issue
- 4
- Pages
- 636-645
- ISSN
- 1536-7290 (ISSN-L)
- 1746-1391
- OpenAlex
- W3019986579
- Cited by
- 64
- References
- 51
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 1
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Sport Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- resistance training, FGF21, myostatin, insulin resistance, type 2 diabetes, older men, muscle strength, HOMA-IR, aging, exercise intervention
- MeSH terms
- Aged, Aged, 80 and over, Body Weight, Diabetes Mellitus, Type 2, Fasting, Fibroblast Growth Factors, Humans, Insulin Resistance, Male, Time Factors, Body Mass Index, Muscle Strength, Resistance Training, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.